Skip to main content
Erschienen in: Current Bladder Dysfunction Reports 3/2023

09.09.2023

Management of Elevated Post-Void Residual Volume

verfasst von: Matan Mekayten, Jaspreet S. Sandhu

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Elevated post-void residual volume (ePVR) also known as chronic urinary retention (CUR) is a chronic condition of incomplete bladder emptying in the absence of pain or discomfort. ePVR may be secondary to several etiologies: obstructive, neurogenic, vascular, myogenic, or a combination of these. It can be further divided into symptomatic (e.g., accompanied with lower urinary tract symptoms), or asymptomatic. In this article, we sought to review the literature regarding definition of ePVR, etiology, clinical significance, initial assessment, treatment, and follow-up.

Recent Findings

We performed a systematic review of current literature and leading urology association guidelines regarding the management of CUR. We recommend using a cut off for of greater than 300mL, in two separate measurements at least 6 months apart for the definition of CUR. Patient with CUR should be divided to low- and high-risk patients, according to their risk of developing complication related to urinary stasis or high intravesical pressure. The management and follow-up recommendations are different in both group and should be aimed at reducing complications and improving quality of life. While low-risk asymptomatic patients may be followed conservatively, high-risk patients should be monitored closely for worsening renal function and interventions may be needed in the high-risk group.

Summary

CUR is a chronic condition whose pathogenesis and complications are not fully understood. Management and follow-up of patients with CUR should be tailored to patient risk. Further research is necessary to better understand the clinical course, pathophysiology, and optimal therapeutic and diagnostic approach.
Literatur
1.•
Zurück zum Zitat Kaplan SA, Wein AJ, Staskin DR, Roehrborn CG, Steers WD. Urinary retention and post-void residual urine in men: separating truth from tradition. J Urol. 2008;180(1):47–54. This article is one of the pivotal studies reviewing the literature regarding CUR, it provides comprehensive review aiming to separate evidence-based, from expert-opinion-only arguments in the diagnosis and management of CUR patients.PubMedCrossRef Kaplan SA, Wein AJ, Staskin DR, Roehrborn CG, Steers WD. Urinary retention and post-void residual urine in men: separating truth from tradition. J Urol. 2008;180(1):47–54. This article is one of the pivotal studies reviewing the literature regarding CUR, it provides comprehensive review aiming to separate evidence-based, from expert-opinion-only arguments in the diagnosis and management of CUR patients.PubMedCrossRef
2.
Zurück zum Zitat Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49.PubMedCrossRef Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49.PubMedCrossRef
4.
Zurück zum Zitat Asimakopoulos AD, De Nunzio C, Kocjancic E, Tubaro A, Rosier PF, Finazzi-Agrò E. Measurement of post-void residual urine. Neurourol Urodyn. 2016;35(1):55–7.PubMedCrossRef Asimakopoulos AD, De Nunzio C, Kocjancic E, Tubaro A, Rosier PF, Finazzi-Agrò E. Measurement of post-void residual urine. Neurourol Urodyn. 2016;35(1):55–7.PubMedCrossRef
5.
Zurück zum Zitat Kim TH, Kim HS, Park JW, Lim OK, Park KD, Lee JK. Falsely elevated postvoid residual urine volume in uterine myoma. Ann Rehabil Med. 2017 Apr;41(2):332–6.PubMedPubMedCentralCrossRef Kim TH, Kim HS, Park JW, Lim OK, Park KD, Lee JK. Falsely elevated postvoid residual urine volume in uterine myoma. Ann Rehabil Med. 2017 Apr;41(2):332–6.PubMedPubMedCentralCrossRef
7.•
Zurück zum Zitat Negro CLA, Muir GH. Chronic urinary retention in men: how we define it, and how does it affect treatment outcome. BJU Int. 2012;110(11):1590–4. This study reviews the impact of chronic urinary retention on patients outcome. Negro et al, provide a high-quality review on the evidence supporting various definitions of CUR, as well as the role of CUR in the diagnosis and management of CUR patients.PubMedCrossRef Negro CLA, Muir GH. Chronic urinary retention in men: how we define it, and how does it affect treatment outcome. BJU Int. 2012;110(11):1590–4. This study reviews the impact of chronic urinary retention on patients outcome. Negro et al, provide a high-quality review on the evidence supporting various definitions of CUR, as well as the role of CUR in the diagnosis and management of CUR patients.PubMedCrossRef
8.•
Zurück zum Zitat Non-neurogenic chronic urinary retention: consensus definition, management strategies, and future opportunities-American Urological Association [Internet]. [cited 2021 Dec 19]. Available from: https://www.auanet.org/guidelines/guidelines/chronic-urinary-retention. This is one of the key resources in the management of PVR and provides evidence-based, risk-stratified approach of the management of chronic urinary retention. The AUA guidelines build a consensus definition of CUR, which allows standartization and future research. Non-neurogenic chronic urinary retention: consensus definition, management strategies, and future opportunities-American Urological Association [Internet]. [cited 2021 Dec 19]. Available from: https://​www.​auanet.​org/​guidelines/​guidelines/​chronic-urinary-retention. This is one of the key resources in the management of PVR and provides evidence-based, risk-stratified approach of the management of chronic urinary retention. The AUA guidelines build a consensus definition of CUR, which allows standartization and future research.
9.
Zurück zum Zitat Decalf V, Monaghan TF, Denys MA, Petrovic M, Pieters R, Weiss JP, et al. Circadian patterns in postvoid residual and voided percentage among older women with urinary incontinence. J Clin Med. 2020;9(4):922.PubMedPubMedCentralCrossRef Decalf V, Monaghan TF, Denys MA, Petrovic M, Pieters R, Weiss JP, et al. Circadian patterns in postvoid residual and voided percentage among older women with urinary incontinence. J Clin Med. 2020;9(4):922.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Abrams PH, Dunn M, George N. Urodynamic findings in chronic retention of urine and their relevance to results of surgery. BMJ. 1978;2(6147):1258–60.PubMedPubMedCentralCrossRef Abrams PH, Dunn M, George N. Urodynamic findings in chronic retention of urine and their relevance to results of surgery. BMJ. 1978;2(6147):1258–60.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Osman NI, Chapple CR. Contemporary concepts in the aetiopathogenesis of detrusor underactivity. Nat Rev Urol. 2014;11:639–48.PubMedCrossRef Osman NI, Chapple CR. Contemporary concepts in the aetiopathogenesis of detrusor underactivity. Nat Rev Urol. 2014;11:639–48.PubMedCrossRef
13.
Zurück zum Zitat Wein AJ. Re: does defective volume sensation contribute to detrusor underactivity? J Urol. 2017;197(1):218–8.PubMed Wein AJ. Re: does defective volume sensation contribute to detrusor underactivity? J Urol. 2017;197(1):218–8.PubMed
14.
Zurück zum Zitat Stoffel JT. Non-neurogenic chronic urinary retention: what are we treating? Curr Urol Rep. 2017;18(9):74.PubMedCrossRef Stoffel JT. Non-neurogenic chronic urinary retention: what are we treating? Curr Urol Rep. 2017;18(9):74.PubMedCrossRef
15.
Zurück zum Zitat Aldamanhori R, Chapple CR. Underactive bladder, detrusor underactivity, definition, symptoms, epidemiology, etiopathogenesis, and risk factors. Curr Opin Urol. 2017 May;27(3):293–9.PubMedCrossRef Aldamanhori R, Chapple CR. Underactive bladder, detrusor underactivity, definition, symptoms, epidemiology, etiopathogenesis, and risk factors. Curr Opin Urol. 2017 May;27(3):293–9.PubMedCrossRef
16.
Zurück zum Zitat Truzzi JCI, Almeida FMR, Nunes EC, Sadi MV. Residual urinary volume and urinary tract infection—when are they linked? J Urol. 2008;180(1):182–5.PubMedCrossRef Truzzi JCI, Almeida FMR, Nunes EC, Sadi MV. Residual urinary volume and urinary tract infection—when are they linked? J Urol. 2008;180(1):182–5.PubMedCrossRef
17.
Zurück zum Zitat Breyer BN, Shinohara K. Re: residual urinary volume and urinary tract infection—when are they linked? J Urol. 2009;181(2):919–20.PubMedCrossRef Breyer BN, Shinohara K. Re: residual urinary volume and urinary tract infection—when are they linked? J Urol. 2009;181(2):919–20.PubMedCrossRef
18.
Zurück zum Zitat Töz E, Kurt S, Sahin Ç, Canda MT. Frequency of recurrent urinary tract infection in patients with pelvic organ prolapse. Res Rep Urol. 2015 Jan;28(7):9–12. Töz E, Kurt S, Sahin Ç, Canda MT. Frequency of recurrent urinary tract infection in patients with pelvic organ prolapse. Res Rep Urol. 2015 Jan;28(7):9–12.
19.
Zurück zum Zitat May M, Brookman -Amissah Sabine, Hoschke B, Gilfrich C, Braun KP, Kendel F. Post-void residual urine as a predictor of urinary tract infection—is there a cutoff value in asymptomatic men? J Urol. 2009;181(6):2540–4.PubMedCrossRef May M, Brookman -Amissah Sabine, Hoschke B, Gilfrich C, Braun KP, Kendel F. Post-void residual urine as a predictor of urinary tract infection—is there a cutoff value in asymptomatic men? J Urol. 2009;181(6):2540–4.PubMedCrossRef
20.
Zurück zum Zitat Omli R, Skotnes LH, Mykletun A, Bakke AM, Kuhry E. Residual urine as a risk factor for lower urinary tract infection: a 1-year follow-up study in nursing homes. J Am Geriatr Soc. 2008;56(5):871–4.PubMedCrossRef Omli R, Skotnes LH, Mykletun A, Bakke AM, Kuhry E. Residual urine as a risk factor for lower urinary tract infection: a 1-year follow-up study in nursing homes. J Am Geriatr Soc. 2008;56(5):871–4.PubMedCrossRef
21.
Zurück zum Zitat Hampson SJ, Noble JG, Rickards D, Milroy EJG. Does residual urine predispose to urinary tract infection? Br J Urol. 1992;70(5):506–8.PubMedCrossRef Hampson SJ, Noble JG, Rickards D, Milroy EJG. Does residual urine predispose to urinary tract infection? Br J Urol. 1992;70(5):506–8.PubMedCrossRef
22.
Zurück zum Zitat Barabas G, Mölstad S. No association between elevated post-void residual volume and bacteriuria in residents of nursing homes. Scand J Prim Health Care. 2005;23(1):52–6.PubMedCrossRef Barabas G, Mölstad S. No association between elevated post-void residual volume and bacteriuria in residents of nursing homes. Scand J Prim Health Care. 2005;23(1):52–6.PubMedCrossRef
23.
Zurück zum Zitat Kolman C, Girman CJ, Jacobsen SJ, Lieber MM. Distribution of post-void residual urine volume in randomly selected men. J Urol. 1999;161(1):122–7.PubMedCrossRef Kolman C, Girman CJ, Jacobsen SJ, Lieber MM. Distribution of post-void residual urine volume in randomly selected men. J Urol. 1999;161(1):122–7.PubMedCrossRef
24.
Zurück zum Zitat Scofield S, Kaplan SA. Voiding dysfunction in men: pathophysiology and risk factors. Int J Impot Res. 2008;20(S3):S2–10.PubMedCrossRef Scofield S, Kaplan SA. Voiding dysfunction in men: pathophysiology and risk factors. Int J Impot Res. 2008;20(S3):S2–10.PubMedCrossRef
25.
Zurück zum Zitat Roehrborn CG, Kaplan SA, Lee MW, Slawin KM, McVary KT, Kusek JW, et al. 1638: baseline post void residual urine volume as a predictor of urinary outcomes in men with BPH in the MTOPS study. J Urol. 2005;173(4S):443–4.CrossRef Roehrborn CG, Kaplan SA, Lee MW, Slawin KM, McVary KT, Kusek JW, et al. 1638: baseline post void residual urine volume as a predictor of urinary outcomes in men with BPH in the MTOPS study. J Urol. 2005;173(4S):443–4.CrossRef
26.
Zurück zum Zitat Rule AD, Jacobson DJ, McGREE ME, Girman CJ, Lieber MM, Jacobsen SJ. Longitudinal changes in post-void residual and voided volume among community dwelling men. J Urol. 2005;174(4 Part 1):1317–22.PubMedCrossRef Rule AD, Jacobson DJ, McGREE ME, Girman CJ, Lieber MM, Jacobsen SJ. Longitudinal changes in post-void residual and voided volume among community dwelling men. J Urol. 2005;174(4 Part 1):1317–22.PubMedCrossRef
27.
Zurück zum Zitat Mochtar CA, Kiemeney LALM, Van Riemsdijk MM, Laguna MP, Debruyne FMJ, De La Rosette JJMCH. Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasia. J Urol. 2006;175(1):213–6.PubMedCrossRef Mochtar CA, Kiemeney LALM, Van Riemsdijk MM, Laguna MP, Debruyne FMJ, De La Rosette JJMCH. Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasia. J Urol. 2006;175(1):213–6.PubMedCrossRef
29.
Zurück zum Zitat Styles RA, Neal DE, Griffiths CJ, Ramsden PD. Long-term monitoring of bladder pressure in chronic retention of urine: the relationship between detrusor activity and upper tract dilatation. J Urol. 1988;140(2):330–4.PubMedCrossRef Styles RA, Neal DE, Griffiths CJ, Ramsden PD. Long-term monitoring of bladder pressure in chronic retention of urine: the relationship between detrusor activity and upper tract dilatation. J Urol. 1988;140(2):330–4.PubMedCrossRef
30.
Zurück zum Zitat Rule AD, Lieber MM, Jacobsen SJ. Is benign prostatic hyperplasia a risk factor for chronic renal failure? J Urol. 2005;173(3):691–6.PubMedCrossRef Rule AD, Lieber MM, Jacobsen SJ. Is benign prostatic hyperplasia a risk factor for chronic renal failure? J Urol. 2005;173(3):691–6.PubMedCrossRef
31.
Zurück zum Zitat Yamasaki T, Naganuma T, Iguchi T, Kuroki Y, Kuwabara N, Takemoto Y, et al. Association between chronic kidney disease and small residual urine volumes in patients with benign prostatic hyperplasia. Nephrology. 2011;16(3):335–9.PubMedCrossRef Yamasaki T, Naganuma T, Iguchi T, Kuroki Y, Kuwabara N, Takemoto Y, et al. Association between chronic kidney disease and small residual urine volumes in patients with benign prostatic hyperplasia. Nephrology. 2011;16(3):335–9.PubMedCrossRef
32.
Zurück zum Zitat Hong SK, Lee ST, Jeong SJ, Byun SS, Hong YK, Park DS, et al. Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia. BJU Int. 2010;105(10):1424–8.PubMedCrossRef Hong SK, Lee ST, Jeong SJ, Byun SS, Hong YK, Park DS, et al. Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia. BJU Int. 2010;105(10):1424–8.PubMedCrossRef
33.•
Zurück zum Zitat Childs MA, Mynderse LA, Rangel LJ, Wilson TM, Lingeman JE, Krambeck AE. Pathogenesis of bladder calculi in the presence of urinary stasis. J Urol. 2013;189(4):1347–51. Childs et al studied prospectively the impact of urinary stasis secondary to bladder outlet obstruction on stone development in male patients.PubMedCrossRef Childs MA, Mynderse LA, Rangel LJ, Wilson TM, Lingeman JE, Krambeck AE. Pathogenesis of bladder calculi in the presence of urinary stasis. J Urol. 2013;189(4):1347–51. Childs et al studied prospectively the impact of urinary stasis secondary to bladder outlet obstruction on stone development in male patients.PubMedCrossRef
34.
Zurück zum Zitat Philippou P, Volanis D, Kariotis I, Serafetinidis E, Delakas D. Prospective comparative study of endoscopic management of bladder lithiasis: is prostate surgery a necessary adjunct? Urology. 2011;78(1):43–7.PubMedCrossRef Philippou P, Volanis D, Kariotis I, Serafetinidis E, Delakas D. Prospective comparative study of endoscopic management of bladder lithiasis: is prostate surgery a necessary adjunct? Urology. 2011;78(1):43–7.PubMedCrossRef
35.
Zurück zum Zitat Huang W, Cao JJ, Cao M, Wu HS, Yang YY, Xu ZM, et al. Risk factors for bladder calculi in patients with benign prostatic hyperplasia. Medicine (Baltimore). 2017;96(32):e7728.PubMedPubMedCentralCrossRef Huang W, Cao JJ, Cao M, Wu HS, Yang YY, Xu ZM, et al. Risk factors for bladder calculi in patients with benign prostatic hyperplasia. Medicine (Baltimore). 2017;96(32):e7728.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Verhamme KMC, Sturkenboom MCJM, Stricker BHC, Bosch R. Drug-induced urinary retention. Drug Saf. 2008;31(5):373–88.PubMedCrossRef Verhamme KMC, Sturkenboom MCJM, Stricker BHC, Bosch R. Drug-induced urinary retention. Drug Saf. 2008;31(5):373–88.PubMedCrossRef
37.
Zurück zum Zitat Serlin DC, Heidelbaugh JJ, Stoffel JT. Urinary retention in adults: evaluation and initial management. Am Fam Physician. 2018;98(8):496–503.PubMed Serlin DC, Heidelbaugh JJ, Stoffel JT. Urinary retention in adults: evaluation and initial management. Am Fam Physician. 2018;98(8):496–503.PubMed
38.
Zurück zum Zitat Bright E, Cotterill N, Drake M, Abrams P. Developing and validating the International Consultation on Incontinence Questionnaire bladder diary. Eur Urol. 2014;66(2):294–300.PubMedCrossRef Bright E, Cotterill N, Drake M, Abrams P. Developing and validating the International Consultation on Incontinence Questionnaire bladder diary. Eur Urol. 2014;66(2):294–300.PubMedCrossRef
39.
Zurück zum Zitat Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I—initial work-up and medical management. J Urol. 2021;206(4):806–17.PubMedCrossRef Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I—initial work-up and medical management. J Urol. 2021;206(4):806–17.PubMedCrossRef
40.
Zurück zum Zitat Fisher E, Subramonian K, Omar MI. The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men. Cochrane Database Syst Rev. 2014;10(6):CD006744. Fisher E, Subramonian K, Omar MI. The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men. Cochrane Database Syst Rev. 2014;10(6):CD006744.
42.
Zurück zum Zitat Martín-Merino E, García-Rodríguez LA, Massó-González EL, Roehrborn CG. Do oral antimuscarinic drugs carry an increased risk of acute urinary retention? J Urol. 2009;182(4):1442–8.PubMedCrossRef Martín-Merino E, García-Rodríguez LA, Massó-González EL, Roehrborn CG. Do oral antimuscarinic drugs carry an increased risk of acute urinary retention? J Urol. 2009;182(4):1442–8.PubMedCrossRef
43.
Zurück zum Zitat Sacco E, Bientinesi R. Mirabegron: a review of recent data and its prospects in the management of overactive bladder. Ther Adv Urol. 2012;4(6):315–24.PubMedPubMedCentralCrossRef Sacco E, Bientinesi R. Mirabegron: a review of recent data and its prospects in the management of overactive bladder. Ther Adv Urol. 2012;4(6):315–24.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part II—surgical evaluation and treatment. J Urol. 2021;206(4):818–26.PubMedCrossRef Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part II—surgical evaluation and treatment. J Urol. 2021;206(4):818–26.PubMedCrossRef
45.
Zurück zum Zitat Campeau L, Al-Afraa T, Corcos J. Evaluation and management of urinary retention after a suburethral sling procedure in women. Curr Urol Rep. 2008;9(5):412–8.PubMedCrossRef Campeau L, Al-Afraa T, Corcos J. Evaluation and management of urinary retention after a suburethral sling procedure in women. Curr Urol Rep. 2008;9(5):412–8.PubMedCrossRef
46.
Zurück zum Zitat Jonas U, Fowler CJ, Chancellor MB, Elhilali MM, Fall M, Gajewski JB, et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol. 2001;165(1):15–9.PubMedCrossRef Jonas U, Fowler CJ, Chancellor MB, Elhilali MM, Fall M, Gajewski JB, et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol. 2001;165(1):15–9.PubMedCrossRef
47.
Zurück zum Zitat Gross C, Habli M, Lindsell C, South M. Sacral neuromodulation for nonobstructive urinary retention: a meta-analysis. Female Pelvic Med Reconstr Surg. 2010;16(4):249–53.PubMedCrossRef Gross C, Habli M, Lindsell C, South M. Sacral neuromodulation for nonobstructive urinary retention: a meta-analysis. Female Pelvic Med Reconstr Surg. 2010;16(4):249–53.PubMedCrossRef
48.
Zurück zum Zitat White WM, Dobmeyer-Dittrich C, Klein FA, Wallace LS. Sacral nerve stimulation for treatment of refractory urinary retention: long-term efficacy and durability. Urology. 2008;71(1):71–4.PubMedCrossRef White WM, Dobmeyer-Dittrich C, Klein FA, Wallace LS. Sacral nerve stimulation for treatment of refractory urinary retention: long-term efficacy and durability. Urology. 2008;71(1):71–4.PubMedCrossRef
49.
Zurück zum Zitat Szymański JK, Słabuszewska-Jóźwiak A, Jakiel G. Fowler’s syndrome—the cause of urinary retention in young women, often forgotten, but significant and challenging to treat. Int J Environ Res Public Health. 2021;18(6):3310.PubMedPubMedCentralCrossRef Szymański JK, Słabuszewska-Jóźwiak A, Jakiel G. Fowler’s syndrome—the cause of urinary retention in young women, often forgotten, but significant and challenging to treat. Int J Environ Res Public Health. 2021;18(6):3310.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Coolen RL, Groen J, Scheepe JR, Blok BFM. Transcutaneous electrical nerve stimulation and percutaneous tibial nerve stimulation to treat idiopathic nonobstructive urinary retention: a systematic review. Eur Urol Focus. 2021 Sep;7(5):1184–94.PubMedCrossRef Coolen RL, Groen J, Scheepe JR, Blok BFM. Transcutaneous electrical nerve stimulation and percutaneous tibial nerve stimulation to treat idiopathic nonobstructive urinary retention: a systematic review. Eur Urol Focus. 2021 Sep;7(5):1184–94.PubMedCrossRef
52.
Zurück zum Zitat Ninkovic M, Stenzl A, Schwabegger A, Bartsch G, Prosser R. Free neurovascular transfer of latissimus dorsi muscle for the treatment of bladder acontractility: II Clinical results. J Urol. 2003;169(4):1379–83.PubMedCrossRef Ninkovic M, Stenzl A, Schwabegger A, Bartsch G, Prosser R. Free neurovascular transfer of latissimus dorsi muscle for the treatment of bladder acontractility: II Clinical results. J Urol. 2003;169(4):1379–83.PubMedCrossRef
54.
Zurück zum Zitat Bates TS, Sugiono M, James ED, Stott MA, Pocock RD. Is the conservative management of chronic retention in men ever justified? BJU Int. 2003;92(6):581–3.PubMedCrossRef Bates TS, Sugiono M, James ED, Stott MA, Pocock RD. Is the conservative management of chronic retention in men ever justified? BJU Int. 2003;92(6):581–3.PubMedCrossRef
55.
Zurück zum Zitat Al-Hayek S, Thomas A, Abrams P. Natural history of detrusor contractility--minimum ten-year urodynamic follow-up in men with bladder outlet obstruction and those with detrusor. Scand J Urol Nephrol Suppl. 2004;215:101–8.CrossRef Al-Hayek S, Thomas A, Abrams P. Natural history of detrusor contractility--minimum ten-year urodynamic follow-up in men with bladder outlet obstruction and those with detrusor. Scand J Urol Nephrol Suppl. 2004;215:101–8.CrossRef
Metadaten
Titel
Management of Elevated Post-Void Residual Volume
verfasst von
Matan Mekayten
Jaspreet S. Sandhu
Publikationsdatum
09.09.2023
Verlag
Springer US
Erschienen in
Current Bladder Dysfunction Reports / Ausgabe 3/2023
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-023-00706-6

Weitere Artikel der Ausgabe 3/2023

Current Bladder Dysfunction Reports 3/2023 Zur Ausgabe

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.